Webinars and Sponsored Roundtables — Register Now

Tuesday, July 21, 2026, 11:00-11:30 AM CT

Learning Objectives:
  • Explain how transparency and manufacturer partnerships improve quality, consistency, and decision-making confidence in specimen management.
  • Evaluate blood collection tubes beyond cost and commodity assumptions, incorporating clinical impact and risk into decision-making.
  • Assess the potential risk points when using a blood collection device that has not been cleared for a specific purpose.

Roundtable presenters Nick Fingland, PhD, PMP, Senior Director, R&D Operations and Science, BD, and Chris Farnsworth, PhD, D(ABCC), Section Head of Clinical Chemistry, Professor of Pathology and Immunology, Washington University School of Medicine.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Wednesday, July 29, 2026, 1:00-2:00 PM ET
Learn about digital pathology technology that is future-ready, yet practical for today’s
laboratory needs.

Webinar presenters Scott Hammond, Senior Systems Consultant, Digital Pathology Division, Wexner Medical Center, Department of Pathology, and Ursula Hofer, Imaging Technologist, Pathology Digital Imaging Lab, Wexner Medical Center, Department of Pathology, and Sandra Banky, PA(ASCP), Director of Operations, Wexner Medical Center, Department of Pathology.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Subspecialties

Interactive Product Guides

Product Spotlight

Werfen 

QUANTA-Lyser 3000

Company

Werfen 

Name of instrument

QUANTA-Lyser 3000

Email

AID.marketing.na@werfen.com

City, State

San Diego, CA

Phone

858-586-9900   

Website

http://www.werfen.com

Type of instrument

immunoassay

List price/First year sold in U.S.

—/2017

Targeted hospital bed size/Targeted test volume

Company manufactures instrument

Other models in this family of analyzers

No. of units in clinical use in U.S./Outside U.S. (countries)

Dimensions (H × W × D)/Instrument footprint

36.6 × 45.3 × 32 in./—

Weight empty/Weight fully loaded

462 lbs./—

No. of different measured assays onboard simultaneously

12–22 (12–22 can be run and calibrated at one time)

No. of user-definable (open chemistry) channels

— (12–22 can be active simultaneously)

Test throughput per hour/Assay run time

assay dependent/—

No. of direct ion-selective electrode channels

Detection methods

Stat time until completion/specimen throughput for Ion-selective electrode

Stat time until completion/specimen throughput for Ion-selective electrode basic metabolic panel

Stat time until completion/specimen throughput for Ion-selective electrode complete metabolic panel

Typical time delay from ordering stat test until aspiration of sample

Fully automated microplate immunoassay system

yes (1 test per well; 96 wells per microplate)

Methodologies supported

enzyme immunoassay

Separation methodologies

coated microwell

Stat time until completion of a ß-hCG test

Stat time until completion of a cTn test

• Typical time delay from test order to aspiration of sample

Reagents refrigerated onboard/Reagents ready to use

no/yes

Reagent lot tracking/Reagent inventory

yes/no

Reagent form/Reagents barcoded

liquid chemistry (open reagent system)/yes

Separate reagent pack for each specimen/for each test run

no/yes

Walkaway capability/Walkaway duration

yes/300 min. or 240 specimens or 540 tests

Design of sample-handling system

rack

Uses washable cuvettes/Uses disposable cuvettes

no/no

Min.–max. sample volume that can be aspirated at one time 

5–1,000 µL

Min. reaction volume/Min. specimen volume/Min. dead volume

30 µL/5 µL/200 µL

Dedicated pediatric sample cup

no

Primary tube sampling

yes

Accommodates most standard tube sizes/Accepts nonstandard tube sizes

yes/no

Pierces caps on primary tubes

no

Protects against probe collision

no

Detects clots/liquid level/short sample

yes/yes/yes

Detection or quantitation for hemolysis, icterus, lipemia, clots

detection for clots; hemolysis, icterus, lipemia not available

Dilutes patient samples onboard/Susceptibility to carryover

yes (can be programmed to perform dilutions prior to analysis)/—

Automatic rerun capability

no

Sample volume can be diluted to rerun out-of-linear-range high results

no

Sample volume can be concentrated to rerun out-of-linear-range low results

no

Autocalibration/Multipoint calibration supported

no (calibrants are not stored onboard)/yes (recommended avg. frequency: per run)

Typical calibration frequency for ISE/therapeutic drugs/drugs of abuse/general chemistries/immunoassays

—/—/—/—/per run

Automatic programmable start/Automatic programmable shutdown

no/no

Onboard real-time QC/Onboard software capability to review QC

yes/yes

Supports multiple QC lot numbers per analyte

no

Waste management

automated collection onboard instrument

Sample barcode-reading capability/Autodiscrimination

yes (Interleaved 2 of 5, UPC, Codabar, Code 39, Code 128, EAN, EAN-128)/no

Lab can control analyzer from remote computer

no

Instrument can diagnose its own malfunctions

no (operator intervention required to order parts)

System malfunctions can be diagnosed via remote monitoring

no

UPS backup power supply

yes

Data-management capability/LIS or EHR systems interfaced

onboard/—

LIS interface provided/Bidirectional interface capability

—/yes (host query)

Modem servicing provided/Service engineer on-site response time

—/24 hrs.

Mean time between failures

— (displays error codes for troubleshooting)

Average scheduled maintenance time by lab personnel

daily: 10 min.; weekly: 30 min.; monthly: none

Maintenance records kept onboard for user/vendor

some records/some records

Maintenance training demonstration module onboard

no

Training included with purchase/Avg. time for basic user training

yes/3 hrs. (at customer site)

Advanced operator training/Extra charge for follow-up or advanced training

yes (at customer or vendor site)/—

Warranty provided/Cost of annual service contract (24 h/7 d)

yes/—

Distinguishing features (supplied by company)

four independent washable probes with two dual probes for individual IFA well washing and mounting media dispensing; reagent integrity and positive patient identification managed through reagent and patient barcode scanning; 240 sample capacity open IFA/ELISA system with 70 reagent and control positions allow for maximum walkaway time

Note

all information listed was provided to CAP TODAY in 2025; company did not provide updated information by 2026 entry deadline

More products
in this guide

Alinity ci-series
ASI Evolution RPR Syphilis Analyzer
DxI 9000 Access Immunoassay Analyzer
Pictus 700 (P700)
Agility Automated ELISA System
AIX1000 Agglutination Instrument
Yumizen C1200
Yumizen C560
VITROS 3600 Immunodiagnostic System
VITROS 4600 Chemistry System
VITROS XT 7600 Integrated System
cobas pro integrated solutions
dIFine P30 Processor
IMMULITE 2000 XPi Immunoassay System
Phadia 250 Laboratory System
B⋅R⋅A⋅H⋅M⋅S KRYPTOR GOLD